They are fully funded untill at least commercialisation and receiving revenue. Potential for cap raise early next year to assist in development of the child app, or prior to starting the FDA approval process depending on the uptake and revenue by that point. Other than that they have kept a tight ship thus far and can only assume they will continue to do so.
Interesting that management did not announce the submitting of application for approval. Perhaps they had an incentive to keep the share price down so that their 1m aud share issue would equate to more shares. Speculating of course.
Congrats to the long term holders, we can finally sleep easy knowing this is going somewhere. Been in it from before the backdoor listing.
The rest of the year will be exciting!
- Forums
- ASX - By Stock
- PCK
- Ann: ePAT Pain Assessment App Secures Regulatory Clearance
Ann: ePAT Pain Assessment App Secures Regulatory Clearance, page-162
-
-
- There are more pages in this discussion • 113 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PCK (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.8¢ |
Change
0.001(3.70%) |
Mkt cap ! $45.80M |
Open | High | Low | Value | Volume |
2.7¢ | 2.8¢ | 2.7¢ | $5.717K | 208.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 375880 | 2.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.8¢ | 1129 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 375880 | 0.027 |
4 | 1000000 | 0.026 |
5 | 1213880 | 0.025 |
3 | 194040 | 0.024 |
2 | 894565 | 0.023 |
Price($) | Vol. | No. |
---|---|---|
0.028 | 1129 | 1 |
0.029 | 439618 | 2 |
0.030 | 66462 | 3 |
0.031 | 313334 | 3 |
0.032 | 25118 | 1 |
Last trade - 13.06pm 01/07/2024 (20 minute delay) ? |
Featured News
PCK (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO
Charles Armstrong
CEO
SPONSORED BY The Market Online